The top 100 FTSE biotech companies rely on the latest research to develop life-saving therapies, improve existing medicine and find treatments against life-threatening diseases worldwide. Researchers have a need for seamless access to the most complete and up-to-date global drug research in order to deliver strong, commercial research initiatives in order to stay ahead of competition and to advance global health.
Springer Nature can help by providing solutions to support the latest research to the biotech industry with a portfolio of Springer Nature journals, eBook collections and databases. Content can be tailored to your needs, saving time by giving your team access to only specific content they need, accessible from a number of devices such as PCs, laptops, tablets or mobile phones at a time that suits their schedule.